Clinical trials can be lifesaving for many cancer patients, so why are participation rates so low? Obstacles like the cost of travel and childcare keep too many patients from receiving experimental care. Our experts explain how the system needs to be restructured to increase access and save lives.
Guest Information:
- Brittani Powell, Cancer Trial Participant
- Dana Dornsife, Founder & Chief Mission and Strategy Officer, Lazarex Cancer Foundation
Medical Notes: Cold Plunge for Your Heart Health, Why New Mothers Shouldn’t Use THC, and This Year’s Historic Hurricane Season
Leave a Reply